2 safe FTSE 100 shares with dividend yields above 4%

Are these the best FTSE 100 shares for dividends and safety?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Today, I’m taking a look at two FTSE 100 shares that I believe offer solid long-term dividend growth potential.

Regulated monopoly

First up is National Grid (LSE: NG), the UK’s largest listed utility company. With a relatively low beta of just 0.48, its shares tend to be less volatile than the wider index, which suggest that National Grid is a less risky investment.

One of the biggest advantages for National Grid, and which explains why it has such a low-risk business model, is the exceptionally high initial costs needed to build infrastructure for electricity transmission and gas distribution. This makes National Grid a natural monopoly, which means it faces no competition whatsoever.

Instead, nearly all of its revenues are regulated by Ofgem, via the RIIO regulatory framework, which determines how much the company is allowed to earn on investments made to its infrastructure assets. These revenues are linked to RPI inflation and don’t depend on volumes or commodity prices. This results in the company generating stable earnings and cash flows year-on-year, and means its shares have staying power.

The company is undergoing a major transformation, which should reinforce its status as a ‘shareholder friendly’ company. In December, the company agreed to sell a 61% stake in its gas distribution network, which should allow it to focus on its faster-growing electricity transmission business.

The sale received the green light from the European Commission last week, which means the deal is expected to close in the coming weeks. And once completed, National Grid intends to return £4bn of its net proceeds to shareholders via a combination of a special dividend and share buybacks. Additionally, National Grid’s rate of earnings growth should pick up following the deal, and that would be further good news for dividend investors.

Annual dividends per share have increased more than 60% over the past decade, with a compound annual growth rate (CAGR) of 5.0% over the past 10 years. Looking forward, National Grid has pledged to grow ordinary dividends at least in line with RPI inflation for the foreseeable future, following a share consolidation later this year, intended to reflect its smaller asset base following the sale of its gas network.

At a current price of 995p a share, National Grid has a dividend yield of 4.5%.

Diversified business model

GlaxoSmithKline‘s (LSE: GSK) dividend safety comes from a combination of two factors: the non-cyclical nature of demand for pharmaceutical products and the company’s unique diversified business model.

In addition to the traditional pharmaceutical business, GSK owns a large consumer healthcare businesses, which generates more than a quarter of its revenues, and a sizeable vaccines business, which accounts for another 16% of group revenues. Together, these two businesses account for a growing proportion of GSK’s revenues and a majority of its earnings growth in recent years.

An anticipated 9% earnings rise at GSK this year gives its shares a reasonable forward P/E rating of 15.4 times. And this would fall to 14.7 times in 2018 on forecasts of further earnings improvement of 4%. With an improving earnings outlook and strong diversification, I reckon GSK represents a great pick for long-term income investors.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Jack Tang has no position in any shares mentioned. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Midnight is celebrated along the River Thames in London with a spectacular and colourful firework display.
Investing Articles

Prediction: this will be the FTSE 100’s next great stock!

This FTSE 250 stock has more than doubled in value during the past five years. Our writer thinks it could…

Read more »

Yellow number one sitting on blue background
Investing Articles

Billionaire Bill Ackman has just 1 magnificent AI stock in his FTSE 100-listed fund

Our writer takes a look at the only AI stock held in the portfolio of FTSE 100-listed Pershing Square Holdings.

Read more »

Stack of British pound coins falling on list of share prices
Investing Articles

2 penny stocks this Fool thinks could deliver phenomenal returns!

Penny stocks are a risky but exciting asset class to invest in, prone to wild volatility. Our writer thinks he's…

Read more »

Buffett at the BRK AGM
Investing Articles

I’ve just met Warren Buffett’s first rule of investing. Here are 3 ways I did it

Harvey Jones has surprised himself by living up to Warren Buffett's most important investment rule. But is his success down…

Read more »

Engineer Project Manager Talks With Scientist working on Computer
Investing Articles

Down 51% in 2024, is this UK growth stock a buy for my Stocks and Shares ISA?

Ben McPoland considers Oxford Nanopore Technologies (LSE:ONT), a UK growth stock that has plunged over 80% since going public in…

Read more »

Young Caucasian woman with pink her studying from her laptop screen
Investing Articles

These 3 growth stocks still look dirt cheap despite the FTSE hitting all-time highs

Harvey Jones is hunting for growth stocks that have missed out on the recent FTSE 100 rally and still look…

Read more »

Chalkboard representation of risk versus reward on a pair of scales
Investing Articles

Here’s how much I’d need to invest in UK income stocks to retire on £25k a year

Harvey Jones is building his retirement plans on a portfolio of top UK dividend income stocks. There are some great…

Read more »

Investing Articles

If I’d invested £5,000 in BT shares three months ago here’s what I’d have today

Harvey Jones keeps returning to BT shares, wondering whether he finally has the pluck to buy them. The cheaper they…

Read more »